Next Article in Journal
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies
Next Article in Special Issue
Antipsoriatic Potential of Quebecol and Its Derivatives
Previous Article in Journal
Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery
Previous Article in Special Issue
Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(5), 968; https://doi.org/10.3390/pharmaceutics14050968
Action Date Notes Link
article xml file uploaded 30 April 2022 15:23 CEST Original file -
article xml uploaded. 30 April 2022 15:23 CEST Update -
article pdf uploaded. 30 April 2022 15:23 CEST Version of Record https://www.mdpi.com/1999-4923/14/5/968/pdf-vor
article html file updated 30 April 2022 15:25 CEST Original file -
article xml file uploaded 18 May 2022 10:04 CEST Update -
article xml uploaded. 18 May 2022 10:04 CEST Update https://www.mdpi.com/1999-4923/14/5/968/xml
article pdf uploaded. 18 May 2022 10:04 CEST Updated version of record https://www.mdpi.com/1999-4923/14/5/968/pdf
article html file updated 18 May 2022 10:10 CEST Update -
article html file updated 2 August 2022 21:48 CEST Update https://www.mdpi.com/1999-4923/14/5/968/html
Back to TopTop